Advanced search
Publication Cover
Infectious Diseases Volume 47, 2015 - Issue 12
Submit an article Journal homepage
230
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

A meta-analysis of HBsAg-positive rate among general Chinese populations aged 1–-59 years

Weilu ZhangFrom the Department of Epidemiology, School of Public Health, Fourth Military Medical University, Xi’an, China
,
Zhaohua JiFrom the Department of Epidemiology, School of Public Health, Fourth Military Medical University, Xi’an, China
,
Ling WangDepartment of Health Statistics, School of Public Health, Fourth Military Medical University, Xi’an, China
,
Dan XiaoFrom the Department of Epidemiology, School of Public Health, Fourth Military Medical University, Xi’an, China
&
Yongping YanFrom the Department of Epidemiology, School of Public Health, Fourth Military Medical University, Xi’an, ChinaCorrespondence[email protected]
Pages 878-888 | Received 30 Nov 2014, Accepted 15 Jun 2015, Published online: 24 Aug 2015

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

A.I.K. Mahanama, B. Samaraweera, T.T. Niroshanie, S.S.S.A.K. Seethagala & J.I. Abeynayake. (2019) Seroprevalence of hepatitis B and C virus infection among clinically suspected patients at state sector hospitals in Sri Lanka; a laboratory-based retrospective study. Infectious Diseases 51:9, pages 706-709.
Read now

Articles from other publishers (10)

Yushi Lin, Luyan Zheng, Kailu Fang, Yang Zheng, Jie Wu & Min Zheng. (2023) Proportion of liver cancer cases and deaths attributable to potentially modifiable risk factors in China. International Journal of Epidemiology.
Crossref
Jinlin Hou, Wendong Chen, Ying Han, Lei Wang, I-Heng Lee, Ling-I Hsu, Dongying Xie, Xueru Yin, Fengqin Hou & Yida Yang. (2021) Shifting demographics and comorbidity burden in adult Chinese urban patients with chronic hepatitis B, 2013 and 2016. Journal of Comparative Effectiveness Research 10:8, pages 647-657.
Crossref
Ming Xie, Hongjiao Quan, Yuan Zeng, Shuqian Yuan, Yinyue Liu & Yide Yang. (2021) Sero-epidemiology study of hepatitis B virus surface antibodies from 2017 to 2019 among Chinese young adults in Hunan Province. Medicine 100:29, pages e26665.
Crossref
Diana Kitala, Agnieszka Klama-Baryła, Małgorzata Kraut, Wojciech Łabuś, Justyna Glik & Marek Kawecki. (2020) The Causes for the Loss of Cellular Material at the Qualification Stage and the Influence of the Patient’s Flora on Culture Infection. Transplantation Proceedings 52:7, pages 2231-2235.
Crossref
Shaoxia Xu, Weihong Zhang, Qiaofeng Wang, Jingtao Cui, Wenjuan Yan, Hongjie Xie & Anping Ni. (2020) Hepatitis B virus serological screen in a general hospital in Beijing from 2008 to 2018, and challenges to our vaccination policy. Vaccine: X 4, pages 100057.
Crossref
Chao Zhang, Qiang Ren & Wenhui Chang. (2020) Epidemiological Features and Risk Factors for Acquiring Hepatitis B, Hepatitis C, and Syphilis in HIV-Infected Patients in Shaanxi Province, Northwest China. International Journal of Environmental Research and Public Health 17:6, pages 1990.
Crossref
Semvua B Kilonzo, Daniel Gunda, Qing Ning & Meifang Han. (2019) Where Hepatitis B and Hepatitis E Meet: Epidemiological and Clinical Aspects. Hepatitis Monthly 19:10.
Crossref
Semvua Bukheti Kilonzo, Yong-li Wang, Qun-qun Jiang, Wen-yu Wu, Peng Wang, Qin Ning & Mei-fang Han. (2019) Superinfective Hepatitis E Virus Infection Aggravates Hepatocytes Injury in Chronic Hepatitis B. Current Medical Science 39:5, pages 719-726.
Crossref
Shuchao Qin, Lei Fan, Jinhua Liang, Robert Gale, Yi Miao, Yujie Wu, Rong Wang, Hui Yang, Wei Wu, Yi Xia, Jiazhu Wu, Huayuan Zhu, Li Wang, Wei Xu & Jianyong Li. (2018) Definition of disease-progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variables. Hematological Oncology 36:4, pages 656-662.
Crossref
Shirin Demma & Geoffrey Dusheiko. (2016) The current treatment situation and definitions of a cure for chronic HBV infection. Future Virology 11:1, pages 79-92.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.